Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 ,inter alia, to consider and approve Intimation of Board Meeting to ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies Ltd has informed BSE that its Board of Directors will meet on Thursday, 9th October 2025 at 4:00 PM at the registered office in Ahmedabad. The primary agenda is to consider and approve the Unaudited Financial Results for the Half Year ended 30th September 2025, along with the Limited Review Report from auditors. Any other business items may also be taken up with the Chairperson's permission. The filing is a standard compliance disclosure under SEBI LODR Regulation 29(1) ahead of the upcoming results announcement.
This is a routine pre-results intimation with no material disclosure. Investors should watch for the actual H1 FY26 (April-September 2025) financial results expected to be released on or after 9th October, which could move the stock if numbers surprise.